Legal Representation
Attorney
Duane M. Byers
USPTO Deadlines
Next Deadline
2056 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-25)
Due Date
March 25, 2031
Grace Period Ends
September 25, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 26, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Mar 25, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 25, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 29, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 9, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 31, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 31, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 31, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 30, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Nov 14, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Nov 14, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Nov 8, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Nov 6, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 29, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 29, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 25, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products focused on endocrinology, namely, medical preparations for the treatment of precocious puberty and for participants receiving gonadotropin releasing hormone agonist therapy for central precocious puberty
Class 041
Publication of clinical trial results in the field of endocrinology
Class 042
Providing medical and scientific research information in the field of pharmaceutical products; carrying out clinical trials for pharmaceutical products; scientific research for medical purposes in the field of endocrinology
Additional Information
Translation
The wording "LIBELULA" has no meaning in a foreign language.
Classification
International Classes
005
041
042